Multiple sclerosis: free light chains in cerebrospinal fluid

Area of Science:

• Neurology
• Immunology
• Biochemistry

Background:

• Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system.
• The role of immunoglobulin free light chains (FLCs) in the pathogenesis of MS is not fully understood.
• Previous studies have focused on FLCs in serum, with limited investigation in cerebrospinal fluid (CSF).

Purpose of the Study:

• To investigate the presence and origin of free light chains (FLCs) in the cerebrospinal fluid (CSF) of patients with multiple sclerosis (MS).
• To differentiate between intrathecal production and systemic origin of FLCs in MS.
• To explore the potential source of FLCs in MS CSF, distinguishing between de novo synthesis and IgG degradation.

Main Methods:

• Analysis of cerebrospinal fluid (CSF) and matched serum samples from 18 MS patients and 14 patients with other neurologic diseases.
• Detection of kappa and lambda free light chains (monomers and dimers) and intact immunoglobulin G (IgG).
• Incubation of control IgG with MS CSF to assess potential FLC release from intact IgG.

Main Results:

• Free light chains (FLCs) were detected in the CSF of 18 MS patients, but not in any control patients.
• Kappa and lambda FLC dimers were common in MS CSF, with monomers less frequent; free heavy chains were absent.
• FLCs were not detected in matched serum samples, and MS CSF did not induce FLC release from control IgG.

Conclusions:

• The presence of FLCs in MS CSF suggests an intrathecal origin.
• Findings indicate that FLCs in MS CSF are likely produced by local plasma cells, not derived from systemic circulation or IgG degradation.
• This study highlights the potential diagnostic and pathogenetic significance of intrathecal FLCs in multiple sclerosis.